tiprankstipranks
Trending News
More News >
Living Cell Technologies Ltd. (LVCLF)
OTHER OTC:LVCLF

Compare Living Cell Technologies (LVCLF) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Living Cell Technologies
$0.01
$24.69M
0.00%
Invex Therapeutics Ltd.
AU$0.12
AU$9.77M
-20.63
85.71%
Regeneus Ltd.
AU$0.47
AU$13.44M
-2.27
50.00%
Chimeric Therapeutics Ltd.
AU$0.01
AU$8.84M
10.00%
Neuroscientific Biopharmaceuticals Ltd.
AU$0.10
AU$46.56M
-11.11
288.89%
Memphasys Ltd
AU$0.01
AU$13.44M
-3.57
0.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LVCLF
Living Cell Technologies
AU:IXC
Invex Therapeutics Ltd.
0.13
0.06
85.71%
AU:CMB
Regeneus Ltd.
0.59
0.18
46.25%
AU:CHM
Chimeric Therapeutics Ltd.
AU:NSB
Neuroscientific Biopharmaceuticals Ltd.
0.14
0.10
250.00%
AU:MEM
Memphasys Ltd
0.01
0.00
0.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts